Poly Medicure Limited Stock NSE India S.E.

Equities

POLYMED

INE205C01021

Medical Equipment, Supplies & Distribution

Delayed NSE India S.E. 05:57:08 2024-04-19 am EDT 5-day change 1st Jan Change
1,566 INR -0.32% Intraday chart for Poly Medicure Limited +0.96% +4.87%
Sales 2024 * 13.64B 163M Sales 2025 * 16.66B 200M Capitalization 151B 1.81B
Net income 2024 * 2.55B 30.49M Net income 2025 * 3.29B 39.38M EV / Sales 2024 * 11 x
Net cash position 2024 * 1.51B 18.06M Net cash position 2025 * 2.64B 31.68M EV / Sales 2025 * 8.91 x
P/E ratio 2024 *
59.2 x
P/E ratio 2025 *
45.9 x
Employees 2,339
Yield 2024 *
0.31%
Yield 2025 *
0.37%
Free-Float 28.64%
More Fundamentals * Assessed data
Dynamic Chart
Transcript : Poly Medicure Limited, Q3 2024 Earnings Call, Feb 02, 2024
Poly Medicure Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Poly Medicure Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Poly Medicure Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023 CI
Poly Medicure Limited Proposes Dividend for the Financial Year 2022-23 CI
Poly Medicure Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Poly Medicure Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Poly Medicure Limited Appoints Ambrish Mithal as Independent Director CI
Poly Medicure Limited Recommends Dividend for the Year Ended March 31, 2022 CI
Poly Medicure Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Poly Medicure Limited Appoints Ravi Prakash as Deputy Company Secretary and Compliance Officer CI
Poly Medicure Limited Recommends Dividend for the Year 2021-2022 CI
Poly Medicure Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
Poly Medicure Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021 CI
Poly Medicure : Incorporates Step-Down Subsidiary in US MT
More news
1 day-0.52%
1 week+0.96%
Current month-1.68%
1 month+5.72%
3 months+7.47%
6 months+13.23%
Current year+4.87%
More quotes
1 week
1 501.00
Extreme 1501
1 616.80
1 month
1 474.65
Extreme 1474.65
1 616.80
Current year
1 361.00
Extreme 1361
1 729.00
1 year
945.00
Extreme 945
1 729.00
3 years
651.10
Extreme 651.1
1 729.00
5 years
165.10
Extreme 165.1
1 729.00
10 years
100.25
Extreme 100.25
1 729.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 95-03-29
Director of Finance/CFO - 21-06-30
Chief Tech/Sci/R&D Officer 57 08-02-17
Members of the board TitleAgeSince
Chairman 86 05-05-25
Director/Board Member 50 20-08-28
Director/Board Member 76 97-09-21
More insiders
Date Price Change Volume
24-04-19 1,566 -0.32% 88 566
24-04-18 1,571 +0.14% 53,408
24-04-16 1,568 +1.17% 92,664
24-04-15 1,550 +0.16% 33,658
24-04-12 1,548 -0.79% 26,577

Delayed Quote NSE India S.E., April 19, 2024 at 05:57 am EDT

More quotes
Poly Medicure Limited is an India-based medical devices company. The Company is engaged in manufacturing and selling medical devices. The Company holds a portfolio of over 375 patents covering a range of products in various areas, including vascular access, renal care, transfusion and diagnostics systems. These products cater to a range of therapeutic segments, such as infusion therapy, oncology, anesthesia and respiratory care, urology, gastroenterology, blood management and blood collection, surgery and wound drainage, dialysis, central venous access catheters, veterinary medical devices, and others. It supplies its products to more than 100 countries across Europe, Africa, the Americas, Australia, and Asia. Its products include IV cannula, arterial cannula, prefilled syringe, nasogastric feeding tube, gastro-duodenal feeding tube, umbilical catheter, irrigation sets, urine drainage catheters and others. It operates ten manufacturing facilities across India, China, Egypt and Italy.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1,574 INR
Average target price
1,748 INR
Spread / Average Target
+11.08%
Consensus